R. David Hoover's Insider Trades & SAST Disclosures
R. David Hoover's most recent trade in Elanco Animal Health Inc was a trade of 25,000 Common Stock done at an average price of $10.9 . Disclosure was reported to the exchange on March 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern R. David Hoover.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elanco Animal Health Inc | R. David Hoover | Director | Purchase of securities on an exchange or from another person at price $ 10.90 per share. | 05 Mar 2025 | 25,000 | 210,000 (0%) | 0% | 10.9 | 272,558 | Common Stock |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Nov 2024 | 18,169 | 96,459 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | R. David Hoover | Director | Purchase of securities on an exchange or from another person at price $ 16.14 per share. | 06 Mar 2024 | 20,000 | 185,000 (0%) | 0% | 16.1 | 322,808 | Common Stock |
| Elanco Animal Health Inc | David R. Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 2,147 | 38,400 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Hoover R. David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 20,374 | 78,290 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 2,846 | 36,252 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 3,180 | 33,405 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 3,404 | 30,224 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Purchase of securities on an exchange or from another person at price $ 9.55 per share. | 13 Mar 2023 | 5,000 | 165,000 (0%) | 0% | 9.6 | 47,750 | Common Stock |
| Elanco Animal Health Inc | R. David Hoover | Director | Purchase of securities on an exchange or from another person at price $ 9.46 per share. | 13 Mar 2023 | 5,000 | 160,000 (0%) | 0% | 9.5 | 47,288 | Common Stock |
| Elanco Animal Health Inc | R. David Hoover | Director | Purchase of securities on an exchange or from another person at price $ 11.13 per share. | 03 Mar 2023 | 10,000 | 155,000 (0%) | 0% | 11.1 | 111,300 | Common Stock |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 872 | 26,820 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 18,649 | 57,916 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 828 | 25,947 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 808 | 25,118 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 859 | 24,310 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Purchase of securities on an exchange or from another person at price $ 15.18 per share. | 09 Sep 2022 | 20,000 | 145,000 (0%) | 0% | 15.2 | 303,614 | Common Stock |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 705 | 23,450 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2022 | 526 | 22,745 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 543 | 22,219 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 450 | 21,675 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Purchase of securities on an exchange or from another person at price $ 23.33 per share. | 20 May 2022 | 10,000 | 125,000 (0%) | 0% | 23.3 | 233,269 | Common Stock |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 421 | 21,225 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 408 | 20,804 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Purchase of securities on an exchange or from another person at price $ 29.00 per share. | 28 Feb 2022 | 5,000 | 115,000 (0%) | 0% | 29 | 145,000 | Common Stock |
| Elanco Animal Health Inc | R. David Hoover | Director | Purchase of securities on an exchange or from another person at price $ 28.66 per share. | 28 Feb 2022 | 5,000 | 110,000 (0%) | 0% | 28.7 | 143,323 | Common Stock |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 375 | 20,395 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 409 | 20,019 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2021 | 751 | 19,610 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Purchase of securities on an exchange or from another person at price $ 29.38 per share. | 30 Nov 2021 | 10,000 | 105,000 (0%) | 0% | 29.4 | 293,794 | Common Stock |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 7,307 | 39,267 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 742 | 18,858 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Purchase of securities on an exchange or from another person at price $ 31.79 per share. | 15 Nov 2021 | 5,000 | 95,000 (0%) | 0% | 31.8 | 158,935 | Common Stock |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 471 | 18,116 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 486 | 17,644 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 464 | 17,158 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Purchase of securities on an exchange or from another person at price $ 31.45 per share. | 13 Aug 2021 | 8,000 | 90,000 (0%) | 0% | 31.4 | 251,592 | Common Stock |
| Elanco Animal Health Inc | R. David Hoover | Director | Purchase of securities on an exchange or from another person at price $ 30.74 per share. | 13 Aug 2021 | 2,000 | 82,000 (0%) | 0% | 30.7 | 61,490 | Common Stock |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 425 | 16,694 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 446 | 16,269 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 430 | 15,822 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Purchase of securities on an exchange or from another person at price $ 32.44 per share. | 11 May 2021 | 25,000 | 70,000 (0%) | 0% | 32.4 | 811,000 | Common Stock |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 488 | 15,391 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 526 | 14,903 | - | - | Deferred Stock Units | |
| Edgewell Personal Care Co | R. David Hoover | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 20,839 | 46,724 (0%) | 0% | 0 | Common Stock | |
| Edgewell Personal Care Co | R. David Hoover | Director | Other type of transaction at price $ 0.00 per share. | 03 Feb 2021 | 10,000 | 0 | - | - | Restricted Stock Equivalents | |
| Edgewell Personal Care Co | R. David Hoover | Director | Other type of transaction at price $ 0.00 per share. | 03 Feb 2021 | 3,944 | 0 | - | - | Restricted Stock Equivalents 2-6-2020 | |
| Edgewell Personal Care Co | R. David Hoover | Director | Other type of transaction at price $ 0.00 per share. | 03 Feb 2021 | 3,156 | 0 | - | - | Restricted Stock Equivalents 2-1-2019 | |
| Edgewell Personal Care Co | R. David Hoover | Director | Other type of transaction at price $ 0.00 per share. | 03 Feb 2021 | 2,072 | 0 | - | - | Restricted Stock Equivalents 1-2-2018 | |
| Edgewell Personal Care Co | R. David Hoover | Director | Other type of transaction at price $ 0.00 per share. | 03 Feb 2021 | 1,667 | 0 | - | - | Restricted Stock Equivalents 1-3-2017 | |
| Elanco Animal Health Inc | R. David Hoover | Director | 31 Dec 2020 | 505 | 13,371 | - | - | Deferred Stock Units | ||
| Elanco Animal Health Inc | R. David Hoover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 5,885 | 41,960 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | R. David Hoover | Director | Purchase of securities on an exchange or from another person at price $ 28.24 per share. | 27 Aug 2020 | 5,000 | 36,075 (0%) | 0% | 28.2 | 141,200 | Common Stock |
| Elanco Animal Health Inc | R. David Hoover | Director | Purchase of securities on an exchange or from another person at price $ 28.62 per share. | 27 Aug 2020 | 5,000 | 45,000 (0%) | 0% | 28.6 | 143,100 | Common Stock |
| Elanco Animal Health Inc | R. David Hoover | Director | Purchase of securities on an exchange or from another person at price $ 26.94 per share. | 21 Aug 2020 | 10,000 | 31,075 (0%) | 0% | 26.9 | 269,400 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges